Transforming Research Into Remedies.

Healthcare Professional
Trusted Provider

Pioneering affordable virotherapy from India, for the world.

Founded in Bangalore, Neovira Therapeutics is among the first companies in India focused on oncolytic virotherapy innovation. Our viruses are engineered to selectively target and destroy cancer cells, transforming one of medicine’s greatest challenges into a new frontier of treatment.

About Us

Why We Are

At Neovira, we harness the power of oncolytic viruses, engineered to replicate within and destroy tumor cells while sparing healthy tissue. This dual action not only targets cancer cells directly but also stimulate the immune system for durable response.

Modern hospital facility
Doctor consultation
Medical procedure
Lead Candidate Efficacy – Demonstrated strong tumor reduction in glioblastoma (GBM) cell cultures and animal models.
Manufacturing Progress – GMP-grade production is currently underway.
Clinical Development – Preparing for upcoming Phase I/II clinical trials.
Pipeline Strategy – Initial focus on GBM, with plans to expand into other brain and solid tumors with high disease burden.